COMMUNIQUÉS West-GlobeNewswire

Cianna Medical Showcased the SAVI SCOUT® Radar Breast Localization System at Premier Inc.’s Annual Breakthroughs Conference
20/06/2018
ALISO VIEJO, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Cianna Medical’s SAVI SCOUT ® Radar Breast Localization System is one of the medical innovations that was showcased in front of thousands of healthcare providers at [...]
Moleculin Receives Approval for Leukemia Clinical Trial
20/06/2018
HOUSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody
20/06/2018
NEW YORK, June 20, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) and Novimmune SA, today announced that the companies have entered into an exclusive global agreement to collaborate on the development and [...]
Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial
20/06/2018
– John Farnam appointed to newly created position of Chief Operating Officer – – Bridget Martell, M.D., and Blake Tomkinson, Ph.D., join as Vice Presidents of Clinical Development – – Registration-directed trial of [...]
Restoration Robotics™ to Sponsor and Participate in The Aesthetic Show™ 2018
20/06/2018
SAN JOSE, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today announced that the Company will be a Premier Sponsor, deliver multiple [...]
genedrive plc: Grant to develop and implement a point-of-care test in the NHS to avoid antibiotic-related hearing loss in newborn children
20/06/2018
For release: 20 June 2018 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the [...]
iTeos Therapeutics Completes $75 Million Series B Financing
20/06/2018
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative next-generation immuno-oncology [...]
Orion Corporation: Managers' transactions - Nina Karvonen
20/06/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers' transactions - Anne Karvonen
20/06/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
ObsEva Announces Pricing of Follow-on Public Offering
20/06/2018
Geneva, Switzerland and Boston, MA - June 20, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Solon Eiendom ASA : Primary insider notification
20/06/2018
(Oslo, Norway, June 19, 2018) UFI AS has today bought 74.688 shares in Solon Eiendom ASA at a price of NOK 29.7396 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Publication of offer document by Nordic Transport Group Holding A/S
20/06/2018
Company Announcement 20 June 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Shire plc : Rule 2.9 Announcement
20/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 20 June 2018 Shire [...]
ERYTECH to Present at JMP Securities Life Science Conference
20/06/2018
LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management
20/06/2018
Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST Allschwil, Switzerland - June 20, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patient has been enrolled into [...]
argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris
20/06/2018
Rapid disease control observed in 4/6 patients Strong PD effect correlates with improvement in PDAI score Favorable tolerability profile; Independent Data Monitoring Committee (IDMC) recommends advancing to cohort 2 [...]
iTeos Therapeutics Completes $75 Million Series B Financing
20/06/2018
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative next-generation immuno-oncology [...]
Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada
20/06/2018
VICTORIA, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today applauds the Canadian government’s historic passing of Bill C-45 (Cannabis Act) to [...]
The Ensign Group Acquires Office Building in Orange County, California
20/06/2018
MISSION VIEJO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]

Pages